NEW HAVEN, Conn., Nov. 16, 2016 -- Woodbridge International, a global mergers and acquisitions firm, is pleased to announce the sale of its client, BigMouth Inc. (“the Company”) to CID Capital.
BigMouth Inc—a global brand synonymous with fun—infuses lifestyle products with their unique wit and knack for visual gags. Popular products include the Giant Frosted Donut Pool Float, the patented Wine Bottle Glass, and the original Prescription Coffee Mug. The Glastonbury, CT company designs and sells its product through leading blue-chip retailers around the world in over 50 countries. The brand is noted for its spot-on anticipation of trends, making it fixture of social and mainstream media. BigMouth Inc is regularly featured on Good Morning America, BuzzFeed, the Today Show, People Magazine, and more.
Based out of Indianapolis, IN, CID Capital is a private equity group focused on high-quality, lower-middle-market companies that have shown a consistent track record of success. The firm holds a diverse portfolio of consumer product brands and other companies.
“This is truly an exciting time for BigMouth Inc.,” noted Founder Steve Wampold, “We were no doubt impressed with CID Capital’s expertise and know they will provide the resources we need to meet our potential as the go-to brand for fun.”
“Even with their current growth, we believe BigMouth Inc. is still in the early pages of their success story,” said Scot Swenberg, Managing Director at CID Capital, “We see a clear path to making the Company a household name. BigMouth will be a great fit in the CID portfolio.”
Headquartered in New Haven, CT, Woodbridge International, a global M&A firm, was founded in 1993 and has 30 offices worldwide.
Don Krier, Managing Director Phone: (203) 389-8400 Ext. 201


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



